Accelerating discovery of liver disease mechanisms
Quick summary
Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Key takeaways
- Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Why it matters
“Accelerating discovery of liver disease mechanisms” illustrates how changes in the AI ecosystem can affect products, workflows and user expectations together. Its lasting significance depends on measurable adoption, cost and safety outcomes.
